Qatar
-
Hamad Medical Corporation signs MoU with Boehringer Ingelheim to transform Qatar’s clinical research
Under the partnership, the two organizations will work together to enhance HMC’s Clinical Trials Unit (CTU), strengthen research expertise, and develop initiatives that support the continued growth of Qatar’s healthcare sector.
-
Sidra Medicine debuts Medical Observership Program for healthcare workforce development
The newly launched Medical Observership Program offers structured observational learning opportunities within one of the region’s leading tertiary academic medical centers.
-
Sidra Medicine reports successful use of setmelanotide in rare childhood hypothalamic obesity cases
The report highlights how a targeted, mechanism-based approach helped manage a rare and complex form of obesity that developed after severe brain injury in infancy.
-
Future HSV-1 vaccine could avert over 40M infections, Qatar study finds
The findings come from a mathematical modeling study published in Science Advances, which offers the first population-level estimates of how an HSV-1 vaccine could reshape disease trends.
-
Sidra Medicine earns Elite ANCC Pathway to Excellence Designation with Distinction in Qatar
The ANCC Pathway to Excellence framework evaluates organizations on leadership, safety, professional development, workplace culture, and shared decision-making.
-
Sidra Medicine expands pediatric orthopedic sports care with growth-sparing techniques in Qatar
Growing Demand for Pediatric Sports Medicine
The service, led by Dr. Alkhatib, offers comprehensive care that combines advanced surgical techniques with customized rehabilitation programs. -
Sidra Medicine partners with Builders VC MENA to advance healthcare innovation in Qatar
The collaboration enables Sidra Medicine to connect Builders VC’s expertise and extensive network with their clinical teams, patient populations, and technological platforms.
-
Sidra Medicine pioneers access to Sepiapterin for Phenylketonuria patients in Middle East
Phenylketonuria (PKU) affects approximately one in 23,930 newborns globally, with higher prevalence in parts of Europe and the Middle East.
-
Sidra Medicine performs Qatar’s first pediatric stem cell transplant for leukemia patient
This first-of-its-kind transplantation in Qatar highlights Sidra Medicine’s mission to provide advanced and innovative care for children with complex and high-risk diseases.